Oryzon Genomics S.A. (LON:0RDB)

Oryzon Genomics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	176	75	100	118	120	188
Market Cap Growth	-24.89%	-24.89%	-15.50%	-1.34%	-36.45%	75.69%
Enterprise Value	185	82	105	114	104	161
Last Close Price	2.28	1.16	1.69	2.35	2.25	3.16
PS Ratio	28.90	12.31	8.10	8.48	13.42	22.07
PB Ratio	2.44	1.04	1.41	1.83	2.00	2.77
P/TBV Ratio	2.36	1.00	1.36	1.85	2.02	2.78
EV/Sales Ratio	29.46	13.40	8.53	8.19	11.66	18.92
Debt / Equity Ratio	0.19	0.19	0.22	0.31	0.25	0.18
Asset Turnover	0.07	0.07	0.14	0.16	0.11	0.11
Inventory Turnover	67.11	67.11	30.80	8.17	3.55	1.74
Quick Ratio	0.74	0.74	0.87	1.34	3.75	5.47
Current Ratio	0.75	0.75	0.87	1.34	3.76	5.51
Return on Equity (ROE)	-4.34%	-4.34%	-4.35%	-5.88%	-6.37%	-4.96%
Return on Assets (ROA)	-2.61%	-2.61%	-2.71%	-3.45%	-4.63%	-3.08%
Return on Capital (ROIC)	-2.77%	-2.77%	-2.92%	-3.74%	-4.92%	-3.27%
Earnings Yield	-1.72%	-4.05%	-2.92%	-3.18%	-3.29%	-1.62%
FCF Yield	-	-6.28%	-0.50%	-1.44%	-2.67%	-2.37%
Buyback Yield / Dilution	-6.35%	-6.35%	-10.10%	-4.80%	-	-15.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.